Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes significant emotional distress, requiring treatments that focus on mental health and social support, not just hair regrowth.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Baricitinib is effective and safe for treating severe alopecia areata.

Psychological therapies can improve wellbeing in people with hair loss.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Higher FABP4 levels may indicate more severe alopecia areata.

People with severe and long-lasting alopecia areata often have low vitamin D levels, and treatments with vitamin D-like substances might help.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Low vitamin D levels are linked to severe and active alopecia areata.

Some people with alopecia areata, a hair loss condition, get better within a year without treatment, but it can happen again.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Topical minoxidil showed limited effectiveness for hair regrowth in alopecia areata.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Patients found AI helpful for alopecia diagnosis but want it to support, not replace, doctors.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Male pattern baldness doesn't significantly affect mental health or sexual well-being.

Combining antihistamines with topical treatment improves hair regrowth in alopecia areata.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Stem cell treatment improved life quality and sexual function in women with hair loss.

People with alopecia areata may have a higher risk of blood clots.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Type II diabetes is not linked to hair loss in women.

PRP is an effective and safe treatment for hair loss in women.